NEVARO
Providing digital solutions for mental health, wellbeing and performance based on physiological biomarkers and gamification.
- B2B
- B2C
- saas
- commission
- health
- medical devices
- biotechnology
- augmented reality
- deep tech
- virtual reality
- mobile app
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Support Program | ||
| Total Funding | 000k | ||
| EUR | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | (43 %) | (23 %) |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | 2 % | 242 % | (98 %) |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
NEVARO, founded in 2019 by Rita Maçorano (CEO) and her partners, is a digital health company that develops solutions for mental health and wellbeing, using physiological and behavioral biomarkers, along with gamified experiences.
The company offers a platform that provides data-driven information for mental health therapy and healthcare services. Their solutions include VR & AR Exposure Therapy, Immersive Mindfulness, and EMDR, which track key metrics of medical team performance, treatment outcomes, and patient experience.
NEVARO's business model is centered around providing these digital tools to healthcare professionals and organizations, aiming to improve the effectiveness of mental health treatments. Their product, Holi, is an application designed to help with this process.
Keywords: digital health, mental health, wellbeing, physiological biomarkers, gamification, VR therapy, AR therapy, EMDR, healthcare services, data-driven therapy